Effects of Omega-3 Fatty Acids on Outcome After Major Liver Resection
Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
To study the efficacy and safety of intravenous Omegaven™ (vs. Placebo) in reducing
postoperative morbidity and mortality after major liver resection.